Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry

NCT01515345 is registered in ClinicalTrials.gov with Kaiser Franz Josef Hospital as lead sponsor.

NCT NCT01515345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01515345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
Lead sponsor
Kaiser Franz Josef Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
January 31, 2013
Enrollment
1,008 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stent implantation, platelet inhibition